Position in OGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$202,734
-$68,292 QoQ
Shares Held
14,973
-41.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#233
of 626 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vise Technologies, Inc. holds $206,882,600 across 14 Drug Manufacturers - General names. OGN ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
211,863 | $53,806,846 | |
| 2 | LLY |
ELI LILLY & Co
|
34,353 | $41,204,022 | |
| 3 | ABBV |
AbbVie Inc.
|
118,244 | $29,754,920 | |
| 4 | MRK |
Merck & Co., Inc.
|
217,819 | $27,989,741 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
120,100 | $15,173,434 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
141,913 | $8,177,027 | |
| 7 | PFE |
Pfizer Inc
|
314,153 | $7,564,804 | |
| 8 | GSK |
GSK plc
|
138,125 | $7,240,512 |
All Filings in OGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $202,734 | 14,973 | Shares | Sole | 2026-08-11 | |
| 2025-09-30 | $271,026 | 25,377 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $222,823 | 23,019 | Shares | Sole | 2025-08-07 | |
| 2024-12-31 | $237,884 | 15,944 | Shares | Sole | 2025-02-18 | |
| 2024-06-30 | $284,790 | 13,758 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $263,895 | 14,037 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||